Pillo Health, a Boston, MA-based voice-enabled medication and care management platform for the home, secured $11m in Series A funding.
The round was led by Stanley Black & Decker’s corporate venture capital arm with participation from Samsung Ventures and existing investors BioAdvance, Hikma Ventures – the corporate venture capital arm of Hikma Pharmaceuticals PLC (HIK.L) – Hackensack Meridien Health System’s Innovation Center Fund and Civilization Ventures.
The company intends to use the funds to continue development of its HIPAA-compliant technology platform and to develop additional voice-first experiences for partners to deliver digital health solutions into the home.
Led by Emanuele Musini, Co-founder and CEO, Pillo Health offers partner organizations an engaging in-home interface and HIPAA-compliant technology platform to create customized voice-first health and wellness experiences, empowering them to deliver care into the home, enhancing patient connections to their care teams, and aligning with voice-enabled technologies in the healthcare industry.
The company is currently hiring in its Boston, MA and Genoa, Italy offices.